Searched for
SPOROLAC
JB Pharma profit rises 13% to Rs 111 crore in Q2FY23Revenues rose 36% YoY to Rs 809 crore in Q2FY23, compared to Rs 593 crore in Q2FY22.Earnings before interest, depreciation and taxes (EBITD...
- Load More
JB Pharma profit rises 13% to Rs 111 crore in Q2FY23US stocks: S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
RBI Governor asks banks to treat MSMEs as growth partners
SC refuses urgent listing of Bihar encounter PIL seeking CBI probe
RBI MPC: Growth rate could top 7% if oil prices fall further
India extends bidding deadline for deepwater oil and gas blocks for sixth time
Copyright © 2026 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights:
Times Syndication Service